Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 11 , ISSUE 2 ( March-April, 2019 ) > List of Articles


Obstetric Outcome in Women with Intrahepatic Cholestasis: A 3-year Study in a Tertiary Care Hospital in Bengaluru

Vishnupriya KM Naga, Biji Joseph, Manjula S Kalappa

Keywords : Intrahepatic cholestasis, Maternal outcome, Perinatal outcome, Ursodeoxycholic acid

Citation Information : Naga VK, Joseph B, Kalappa MS. Obstetric Outcome in Women with Intrahepatic Cholestasis: A 3-year Study in a Tertiary Care Hospital in Bengaluru. J South Asian Feder Obs Gynae 2019; 11 (2):103-106.

DOI: 10.5005/jp-journals-10006-1662

License: CC BY-NC 4.0

Published Online: 01-06-2019

Copyright Statement:  Copyright © 2019; The Author(s).


Objective: To study the incidence and obstetric outcome of pregnancies complicated by intrahepatic cholestasis. Materials and methods: A retrospective case control study of 60 women with obstetric cholestasis was carried out in the Department of Obstetrics and Gynecology, St. John's Medical College Hospital, Bengaluru from January 2015 to March 2018. Statistical analysis was performed using the Z/T test when appropriate. A p value less than or equal to 0.05 was considered statistically significant. Results: The frequency of intrahepatic cholestasis of pregnancy (ICP) was 60 among 8319 deliveries (7.21%). The most common symptom was generalized pruritus, which appeared in 36.6% during the 2nd trimester and 83.3% in the 3rd trimester of cases. Preeclampsia was seen in 31.6% (3.3% in controls); preterm deliveries were seen in (23% vs 5%). A higher incidence of meconium-stained amniotic fluid (25% vs 6.7%) was noted at delivery. The cesarean section rate was 41.7% vs 23.3%. There was no significant difference in the CTG changes, APGAR score less than 7, intrauterine growth restriction, NICU admission or perinatal mortality between cases and controls. Conclusion: Multidisciplinary approach involving obstetricians, gastroenterologists and neonatologists improved the obstetric outcome. Early diagnosis was done with liver function tests (aminotransferases) and urinary bile salts and bile pigments. In most of the cases, antihistaminics and emollients relieved the symptoms. Ursodeoxycholic acid (UDCA) treatment is found to be effective in reducing the persistent pruritus.

  1. Kenyon AP, Girling JC. Obstetric Cholestasis. In: Studd J. ed. Progress in obstetrics and Gynaecology. Edinburg: Churchhill Livingstone; 2005. pp. 37–56.
  2. UK: Royal College of Obstetricians and Gynaecologists Obstetric cholestasis Green-Top Guideline No 43; page 3 [Updated April 2011]. [Internet] Available from
  3. Kenyon AP, Piercy CN, et al. Obstetric cholestasis, outcome with active management: a series of 70 cases. Bjog-Int J Obstet Gy 2002;109:282–288. DOI: 10.1111/j.1471-0528.2002.01368.x.
  4. Saleh MM, Abdo KR. Intrahepatic Cholestasis of pregnancy: review of the literature and evaluation of current evidence. J Women's Health 2007;16:833–841. DOI: 10.1089/jwh.2007.0158.
  5. Glantz A, Marschall HW, et al. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004;40:467–474. DOI: 10.1002/hep.20336.
  6. Bacq Y, Sapey T, et al. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997;26:358–364. DOI: 10.1002/hep.510260216.
  7. Brites D, Rodrigues CMP, et al. Unusual case of severe cholestasis of pregnancy with early onset, improved by ursodeoxycholic acid administration. Eur J Obstet Gynecol Reprod Biol 1998;76:165–168. DOI: 10.1016/S0301-2115(97)00185-1.
  8. Berg B, Helm G, et al. Cholestasis of Pregnancy – Clinical and Laboratory Studies. Acta Obstet Gynecol Scand 1986;65:107–113. DOI: 10.3109/00016348609158363.
  9. Reyes H. The Spectrum of Liver and Gastrointestinal-Disease Seen in Cholestasis of Pregnancy. Gastroenterol Clin N 1992;21: 905–921.
  10. Shaw D, Frohlich J, et al. A Prospective-Study of 18 Patients with Cholestasis of Pregnancy. Am J Obstet Gynecol 1982;142:621–625. DOI: 10.1016/S0002-9378(16)32430-9.
  11. Arrese M, Reyes H. Intrahepatic cholestasis of pregnancy: a past and present riddle. Ann Hepatol 2006;5:202–205. DOI: 10.1016/S1665-2681(19)32012-5.
  12. Brites D, Rodrigues CM, et al. Relevance of serum bile acid profile in the diagnosis of intrahepatic cholestasis of pregnancy in an high incidence area: Portugal. Eur J Obstet Gynecol Reprod Biol 1998;80:31–38. DOI: 10.1016/S0301-2115(98)00086-4.
  13. Tann NN, Neuberger J, et al. Liver abnormality in pregnancy. Best Pract Res Clin Gasteroenterol 2013;27:565–575. DOI: 10.1016/j.bpg.2013.06.015.
  14. Bacq Y, Sentilhes L, et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta analysis. Gastroenterology 2012;143:1492–1501. DOI: 10.1053/j.gastro.2012.08.004.
  15. Grand Maison S, Durand M, et al. The effect of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: a meta-analysis including nonrandomized studies. J Obstet Gynaecol Can 2014;36:632–641. DOI: 10.1016/S1701-2163(15)30544-2.
  16. Diaferia A, Nicastri P, et al. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynecol Obstet 1996;52:133–140. DOI: 10.1016/0020-7292(95)02528-6.
  17. Schultz F, Hasan A, et al. The protective effect of ursodeoxycholic acid in an in vitro model of the human fetal heart occurs via targeting cardiac fibroblasts. Prog Biophys Mol Biol 2016;120:149–163. DOI: 10.1016/j.pbiomolbio.2016.01.003.
  18. Geenes V, Lövgren-Sandblom A, et al. The reversed feto maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic Acid. PLoS One 2014;9:e83828. DOI: 10.1371/journal.pone.0083828.
  19. Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstetrics and Gynecology 1999;94:189–193. DOI: 10.1016/S0029-7844(99)00254-9.
  20. The journal of obstetrics and Gynecology of India. J Obstet Gynecol India May–June 2010;60(3).
  21. Germain AM, Kato S, et al. Bile acid increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynaecol 2003;189:577–582. DOI: 10.1067/S0002-9378(03)00545-3.
  22. Zapata R, Lorena S, et al. UDCA in the treatment of ICP of pregnancy-a 12 year experience. Liver Int 2005;25:548–554. DOI: 10.1111/j.1478-3231.2004.0996.x.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.